Trial intelligence / Profile preview

Inhaled Mannitol in Cystic Fibrosis

NCT00630812Phase 3Completed

Sponsor
Syntara Limited
Start
Sep 2008
Primary completion
Apr 2010
Modality
Inhalation Devices, Small Molecules
Countries
7
01

Overview

A Phase 3 trial of Bronchitol in cystic fibrosis (CF), sponsored by Syntara Limited. Started Sep 2008; status: completed.

02

Drugs

Bronchitol
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on NCT00630812.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00630812.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call